SRC and neoplasm: Transgenic PKT mice (Ptf1aCre/+; LSL-KrasG12D/+; Tgfbr2flox/flox) were used for in vivo studies to examine tumor volume with the pancreas and overall survival of combined Src and EGFR inhibition.